日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis

血液透析患者循环真菌群特征与心血管死亡率的关系

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.0000000829
Sumida, Keiichi; Mallisetty, Yamini; Chiu, Chi-Yang; Han, Zhongji; Mims, Tahliyah S; Chen, Cheng; Beach, Robert Tyson; Dojcsak, Levente; Sumida, Maki; Zhao, Qi; Bajwa, Amandeep; Peters, Brian M; Seegmiller, Jesse C; Karger, Amy B; Stenvinkel, Peter; Datta, Susmita; Langston, Michael A; Kovesdy, Csaba P; Pierre, Joseph F
微生物学
发表日期：2026
文献求助 收藏

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Mortality in Patients with ESKD: A Pilot Case-Control Study

克隆性造血与终末期肾病患者心血管死亡率的关系：一项初步病例对照研究

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000888
Kumari, Usha; Han, Zhongji; Mallisetty, Yamini; Chiu, Chi-Yang; Castro-Bono, Guillem; Kolekar, Pandurang; Thota, Swapna; Hayes, D Neil; Kovesdy, Csaba P; Ma, Xiaotu; Obeng, Esther A; Sumida, Keiichi
发表日期：2026
文献求助 收藏

Clonal Hematopoiesis in Kidney Disease

肾病中的克隆性造血

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000895
Sumida, Keiichi; Obeng, Esther A; Kovesdy, Csaba P
发表日期：2026
文献求助 收藏

Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the "Omics" Era: Gut and Beyond

“组学”时代慢性肾脏病中新出现的心血管风险因素：肠道及其他

期刊:Mayo Clinic Proceedings
影响因子:6.7
doi:10.1016/j.mayocp.2025.12.001
Sumida, Keiichi; Kovesdy, Csaba P
发表日期：2026
文献求助 收藏

Sarcopenia, sarcopenic obesity, and frailty in individuals with chronic kidney disease: a comprehensive review

慢性肾脏病患者的肌少症、肌少性肥胖和虚弱：一项综合综述

期刊:Kidney Research and Clinical Practice
影响因子:3.8
doi:10.23876/j.krcp.24.207
Chao, Chia-Ter; Kovesdy, Csaba P; Merchant, Reshma Aziz
肥胖
代谢
发表日期：2026
文献求助 收藏

Association of Intravenous Versus Oral Iron Therapy With Clinical Outcomes in Patients With Advanced CKD

静脉铁剂治疗与口服铁剂治疗对晚期慢性肾脏病患者临床结局的影响

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2026.101324
Adeboye, Adedamola M; Shrestha, Prabin; Sumida, Keiichi; Thomas, Fridtjof; Rhee, Connie M; Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P
发表日期：2026
文献求助 收藏

Ambient Temperature and Risk of Renal Colic: A Systematic Review and Meta-analysis

环境温度与肾绞痛风险：系统评价和荟萃分析

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2025.101179
Mazumder, Hoimonty; Gain, Easter Protiva; Shimul, Monir Hossain; Farah, Faizah; Alam, Naznin; Mou, Xichen; Mzayek, Fawaz; Jia, Chunrong; Smeltzer, Matthew P; Zhang, Hongmei; Chang, Howard H; Davis, Robert Lowell; Fu, Joshua S; Kovesdy, Csaba P; Hossain, M Mahbub; Naser, Abu Mohd
痛风
代谢
发表日期：2026
文献求助 收藏

Utilization and clinical characteristics of patients with type 2 diabetes and chronic kidney disease prescribed finerenone in the United States

美国接受非奈利酮治疗的2型糖尿病合并慢性肾病患者的利用情况和临床特征

期刊:Journal of Clinical and Translational Endocrinology
影响因子:3.3
doi:10.1016/j.jcte.2026.100435
Kovesdy, Csaba P; Coleman, Craig I; Johannes, Catherine B; Khan, Anam M; Ziemiecki, Ryan; Layton, J Bradley; Vizcaya, David; Liu, Fangfang; Oberprieler, Nikolaus G
糖尿病
代谢
发表日期：2026
文献求助 收藏

Quantifying Time to Diagnosis of CKD in the United States: Analysis of Electronic Health Records-Linked Retrospective Claims Data

量化美国慢性肾脏病诊断时间：基于电子健康记录链接的回顾性索赔数据的分析

期刊:Kidney360
影响因子:3
doi:10.34067/KID.0000001056
Levy, Adrian R; Chatterjee, Satabdi; Stackland, Sydnie; Donato, Bonnie M K; Zhang, Ling; Kovesdy, Csaba P
发表日期：2026
文献求助 收藏

Temporal Changes in SGLT2 Inhibitor and GLP-1 Receptor Agonist Use in Patients with Chronic Kidney Disease and Type 2 Diabetes, 2012-2023: A US Cohort Study

2012-2023年美国慢性肾病合并2型糖尿病患者SGLT2抑制剂和GLP-1受体激动剂使用情况的时间变化：一项队列研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01825-5
Johannes, Catherine B; Coleman, Craig I; Kovesdy, Csaba P; Khan, Anam M; Ziemiecki, Ryan; Layton, J Bradley; Vizcaya, David; Liu, Fangfang; Oberprieler, Nikolaus G
SGLT2
GLP-1
信号转导
代谢
糖尿病
发表日期：2026
文献求助 收藏